FdaApplication

NDA 021443

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASPEN PHARMA USA INC
application_typeNDA
approval_date2004-05-10

Products (5)

ProductActive ingredientStrengthDosage form
ENJUVIAESTROGENS, CONJUGATED SYNTHETIC B0.9MGTABLET;ORAL
ENJUVIAESTROGENS, CONJUGATED SYNTHETIC B0.45MGTABLET;ORAL
ENJUVIAESTROGENS, CONJUGATED SYNTHETIC B0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
ENJUVIAESTROGENS, CONJUGATED SYNTHETIC B0.3MGTABLET;ORAL
ENJUVIAESTROGENS, CONJUGATED SYNTHETIC B1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

5 products